Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30754367 | 1.00 | NLRP3 (0.36) | NLRP3OPRM1APOBEC3AAPOBEC3GTAS2R46 | |
| SCHEMBL14993444 | 0.89 | ALDH1A1 (0.35) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL8743418 | 0.83 | APOBEC3A (0.37) | APOBEC3AAPOBEC3GTAS2R46ALDH1A1LMNA | |
| SCHEMBL5930466 | 0.82 | NLRP3 (0.40) | NLRP3APOBEC3AAPOBEC3GALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL8743395 | 0.80 | APOBEC3A (0.45) | APOBEC3AAPOBEC3G | |
| SCHEMBL14993011 | 0.79 | CES2 (0.33) | APOBEC3AAPOBEC3GALDH1A1TSHRNPC1 | |
| SCHEMBL14423794 | 0.77 | ALDH1A1 (0.36) | OPRM1ALDH1A1LMNAPOLB | |
| SCHEMBL295519 | 0.77 | ALDH1A1 (0.36) | OPRM1ALDH1A1LMNAPOLB | |
| SCHEMBL22832664 | 0.75 | ALDH1A1 (0.34) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL13849728 | 0.75 | ALDH1A1 (0.40) | ALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| WO-2025070466-A1 | SEAMLESS CAPSULE FOR ORAL CAVITY | 森下仁丹株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20240180219-A1 | SEAMLESS CAPSULE STABLY DISINTEGRABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING THE SAME | MORISHITA JINTAN CO., LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-3888475-B1 | SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME | SUNSHO PHARMACEUTICAL CO LTD (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4316472-A1 | DISINTEGRABLE SEAMLESS CAPSULE THAT IS STABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING SAID SEAMLESS CAPSULE | Morishita Jintan Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023042820-A1 | CARYOPHYLLENE-CONTAINING COMPOSITION | 三生医薬株式会社 | 2023-03-23 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| EP-1721943-B1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORP (JP) | 2010-05-12 | — | — | EP | disclosed |
| US-7538149-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| EP-2020225-A2 | Fragrance composition | Kao Corporation (JP) | 2009-02-04 | — | — | EP | disclosed |
| US-20060258776-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2006-11-16 | — | — | US | disclosed |
| EP-1721943-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-15 | — | — | EP | disclosed |
| EP-1707185-A1 | Solvent materials and methods for preparing fragrance compositions | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2006-10-04 | — | — | EP | disclosed |
| US-20050245407-A1 | Fragrance composition | KAO CORPORATION (JP) | 2005-11-03 | — | — | US | disclosed |
| EP-1552814-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2005-07-13 | — | — | EP | disclosed |
| WO-2000027197-A1 | A COMPOSITION CONTAINING AN INSECT REPELLENT ACTIVE BLEND | THE PROCTER & GAMBLE COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | NLRP3 1810/4885OPRM1 80/4885APOBEC3A 1353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.